RNF38 and nasopharyngeal carcinoma: Our data revealed that compared to control cells, overexpression of RNF38 had no impact on NPC cell sensitivity to cisplatin, regardless of whether the concentration of cisplatin was 10 or 20 μm (Fig. 3B).